Twinbeech Capital LP Relay Therapeutics, Inc. Transaction History

Twinbeech Capital LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$8.24 - $12.97 $2.19 Million - $3.44 Million	265,344 New	265,344 $2.23 Million
Q1 2023 May 15, 2023	SELL	$15.0 - $22.76 $1.59 Million - $2.41 Million	-105,800 Reduced 51.76%	98,599 $1.62 Million
Q4 2022 Feb 14, 2023	BUY	$14.16 - $24.02 $2.58 Million - $4.37 Million	181,881 Added 807.71%	204,399 $3.05 Million
Q3 2022 Nov 14, 2022	BUY	$18.07 - $31.37 $406,900 - $706,389	22,518 New	22,518 $504,000

187

127M

4.2K

1.7K

Ticker RLAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 120,219,000
Market Cap $834M
Description
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...

Get notified when there are updates to the investment portfolio of Twinbeech Capital LP, based on Form 13F filings with the SEC.

Stay updated on Twinbeech Capital LP with notifications on news.